ORIC Pharmaceuticals announced that Rich Heyman, PhD has been appointed acting Chief Executive Officer and Leonard Reyno, MD has joined as Executive Vice President and Chief Medical Officer. Dr. Rich Heyman has over 25 years of biopharma experience. He previously served as CEO of Seragon Pharmaceuticals, as co-founder and CEO of Aragon Pharmaceuticals, as co-founder and Chief Scientific Officer of X-Ceptor Therapeutics, and as Vice President of Research at Ligand Pharmaceuticals.

Dr. Reyno most recently served as Senior Vice President and Chief Medical Officer at Agensys.